91 related articles for article (PubMed ID: 12685314)
1. [HTLV-I-associated myelopathy (HAM)].
Izumo S
Uirusu; 2002 Dec; 52(2):239-44. PubMed ID: 12685314
[No Abstract] [Full Text] [Related]
2. HTLV-I and neurological disease: from tropical spastic paraparesis to HTLV-I-associated myelopathy: what next?
Njamnshi AK; Kuate CT; Muna WF
Neurologist; 2007 Nov; 13(6):391. PubMed ID: 18090720
[No Abstract] [Full Text] [Related]
3. Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load.
Nagai M; Kubota R; Greten TF; Schneck JP; Leist TP; Jacobson S
J Infect Dis; 2001 Jan; 183(2):197-205. PubMed ID: 11120926
[TBL] [Abstract][Full Text] [Related]
4. Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients.
Beilke MA; Japa S; Moeller-Hadi C; Martin-Schild S
Clin Infect Dis; 2005 Sep; 41(6):e57-63. PubMed ID: 16107970
[TBL] [Abstract][Full Text] [Related]
5. Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease.
Jacobson S
J Infect Dis; 2002 Dec; 186 Suppl 2():S187-92. PubMed ID: 12424696
[TBL] [Abstract][Full Text] [Related]
6. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
[TBL] [Abstract][Full Text] [Related]
7. [Immunopathogenesis and treatment of the myelopathy associated to the HTLV-I virus].
Carod-Artal FJ
Rev Neurol; 2009 Feb 1-15; 48(3):147-55. PubMed ID: 19206063
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of human T lymphotropic virus (HTLV)-I-specific T cell clones in HTLV-I-associated myelopathy/tropical spastic paraparesis patients.
Höger TA; Jacobson S; Kawanishi T; Kato T; Nishioka K; Yamamoto K
J Immunol; 1997 Aug; 159(4):2042-8. PubMed ID: 9257872
[TBL] [Abstract][Full Text] [Related]
9. Recent studies on the epidemiology, clinical features and pathogenic mechanisms of HTLV-I associated myelopathy (HAM/TSP) and other diseases associated to HTLV.
Osame M; Nakagawa M; Umehara F; Ijichi S; Moritoyo T; Higuchi I; Usuku K; Arimura K; Izumo S
J Neurovirol; 1997 May; 3 Suppl 1():S50-1. PubMed ID: 9179793
[No Abstract] [Full Text] [Related]
10. Human T lymphotropic virus type 1 (HTLV-1) proviral load in asymptomatic carriers, HTLV-1-associated myelopathy/tropical spastic paraparesis, and other neurological abnormalities associated with HTLV-1 infection.
Silva MT; Harab RC; Leite AC; Schor D; Araújo A; Andrada-Serpa MJ
Clin Infect Dis; 2007 Mar; 44(5):689-92. PubMed ID: 17278060
[TBL] [Abstract][Full Text] [Related]
11. Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis.
Saito M; Nakagawa M; Kaseda S; Matsuzaki T; Jonosono M; Eiraku N; Kubota R; Takenouchi N; Nagai M; Furukawa Y; Usuku K; Izumo S; Osame M
J Infect Dis; 2004 Jan; 189(1):29-40. PubMed ID: 14702150
[TBL] [Abstract][Full Text] [Related]
12. Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis.
Vine AM; Witkover AD; Lloyd AL; Jeffery KJ; Siddiqui A; Marshall SE; Bunce M; Eiraku N; Izumo S; Usuku K; Osame M; Bangham CR
J Infect Dis; 2002 Oct; 186(7):932-9. PubMed ID: 12232833
[TBL] [Abstract][Full Text] [Related]
13. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.
Ureta-Vidal A; Pique C; Garcia Z; Dehée A; Tortevoye P; Désiré N; Gessain A; Chancerel B; Gout O; Lemonnier FA; Cochet M
J Infect Dis; 2001 Mar; 183(6):857-64. PubMed ID: 11237801
[TBL] [Abstract][Full Text] [Related]
14. [Bronchopneumonopathy in HTLV-1 associated myelopathy (HAM) and non-HAM HTLV-1 carriers].
Maruyama I; Mori S; Kawabata M; Osame M
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May; 30(5):775-9. PubMed ID: 1630040
[TBL] [Abstract][Full Text] [Related]
15. Human T lymphotropic virus type I (HTLV-I) proviral load in cerebrospinal fluid: a new criterion for the diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis?
Lezin A; Olindo S; Oliere S; Varrin-Doyer M; Marlin R; Cabre P; Smadja D; Cesaire R
J Infect Dis; 2005 Jun; 191(11):1830-4. PubMed ID: 15871115
[TBL] [Abstract][Full Text] [Related]
16. Reduction in HTLV-I proviral load and spontaneous lymphoproliferation in HTLV-I-associated myelopathy/tropical spastic paraparesis patients treated with humanized anti-Tac.
Lehky TJ; Levin MC; Kubota R; Bamford RN; Flerlage AN; Soldan SS; Leist TP; Xavier A; White JD; Brown M; Fleisher TA; Top LE; Light S; McFarland HF; Waldmann TA; Jacobson S
Ann Neurol; 1998 Dec; 44(6):942-7. PubMed ID: 9851439
[TBL] [Abstract][Full Text] [Related]
17. Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence.
Primo JR; Brites C; Oliveira Mde F; Moreno-Carvalho O; Machado M; Bittencourt AL
Clin Infect Dis; 2005 Aug; 41(4):535-41. PubMed ID: 16028164
[TBL] [Abstract][Full Text] [Related]
18. Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptor.
Azimi N; Jacobson S; Leist T; Waldmann TA
J Immunol; 1999 Oct; 163(7):4064-72. PubMed ID: 10491011
[TBL] [Abstract][Full Text] [Related]
19. HTLV-I associated myelopathy/tropical spastic paraparesis in a 7-year-old boy associated with infective dermatitis.
de Oliveira Mde F; Bittencourt AL; Brites C; Soares G; Hermes C; Almeida FO
J Neurol Sci; 2004 Jul; 222(1-2):35-8. PubMed ID: 15240193
[TBL] [Abstract][Full Text] [Related]
20. Serum concentration and genetic polymorphism in the 5'-untraslated region of VEGF is not associated with susceptibility to HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-I infected individuals.
Saito M; Usuku K; Nobuhara Y; Matsumoto W; Kodama D; Sabouri AH; Izumo S; Arimura K; Osame M
J Neurol Sci; 2004 Apr; 219(1-2):157-61. PubMed ID: 15050452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
